Sign inGet started

Venkataraman Sriram

Insider CIK 1550642 · ANGO Director · OPTN Director, 10% owner · LNTH Director, 10% owner · OSMT Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RVLP RVL Pharmaceuticals plc J Other2023-01-272023-01-301,032,995— $00SEC↗
RVLP RVL Pharmaceuticals plc P Buy2022-08-082022-08-098,000,000$1.55 $12.40M23,730,864SEC↗
OSMT Osmotica Pharmaceuticals p J Other2020-11-202020-11-234,936,926— $00SEC↗
OPTN OptiNose, Inc. A Award deriv2020-06-102020-06-1214,439$5.65 $81.6K14,439SEC↗
OSMT Osmotica Pharmaceuticals p P Buy2020-01-132020-01-151,250,000$5.00 $6.25M15,730,864SEC↗
OPTN OptiNose, Inc. S Sale2019-11-252019-11-26291,516$9.17 $2.67M3,328,648SEC↗
OPTN OptiNose, Inc. S Sale2019-11-252019-11-2670,762$9.17 $648.9K807,995SEC↗
OPTN OptiNose, Inc. S Sale2019-11-252019-11-26887,722$9.17 $8.14M10,136,374SEC↗
OPTN OptiNose, Inc. A Award deriv2019-06-062019-06-1014,439$6.60 $95.3K14,439SEC↗
OPTN OptiNose, Inc. S Sale2018-06-112018-06-13162,754$20.92 $3.40M878,757SEC↗
OPTN OptiNose, Inc. S Sale2018-06-112018-06-13670,487$20.92 $14.03M3,620,164SEC↗
OPTN OptiNose, Inc. S Sale2018-06-112018-06-132,041,759$20.92 $42.71M11,024,096SEC↗
OPTN OptiNose, Inc. A Award deriv2018-06-072018-06-1114,439$22.50 $324.9K14,439SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19914,916— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19222,089— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19824,986— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19270,915— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-1965,761— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-192,786,097— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19116,529— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-1928,286— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19216,189— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19354,855— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-19216,189— $00SEC↗
OPTN OptiNose, Inc. C Conversion deriv2017-10-172017-10-1917,233— $00SEC↗
OPTN OptiNose, Inc. C Conversion2017-10-172017-10-193,966,107— $04,290,651SEC↗
OPTN OptiNose, Inc. C Conversion2017-10-172017-10-1912,077,563— $013,065,855SEC↗
OPTN OptiNose, Inc. A Award2017-10-172017-10-1970,763$16.00 $1.13M1,041,511SEC↗
OPTN OptiNose, Inc. A Award2017-10-172017-10-19291,516$16.00 $4.66M4,290,651SEC↗
OPTN OptiNose, Inc. A Award2017-10-172017-10-19887,721$16.00 $14.20M988,292SEC↗
OPTN OptiNose, Inc. C Conversion2017-10-172017-10-19962,735— $01,041,511SEC↗
LNTH Lantheus Holdings, Inc. S Sale2017-03-172017-03-21450,722$12.20 $5.50M1,846,996SEC↗
LNTH Lantheus Holdings, Inc. S Sale2017-03-172017-03-21840,000$12.20 $10.25M3,442,208SEC↗
LNTH Lantheus Holdings, Inc. S Sale2017-03-172017-03-211,709,278$12.20 $20.85M7,004,395SEC↗
LNTH Lantheus Holdings, Inc. S Sale2016-11-212016-11-23700,000$9.00 $6.30M4,282,208SEC↗
LNTH Lantheus Holdings, Inc. S Sale2016-11-212016-11-23375,601$9.00 $3.38M2,297,718SEC↗
LNTH Lantheus Holdings, Inc. S Sale2016-11-212016-11-231,424,399$9.00 $12.82M8,713,673SEC↗